Moreno Galleni

Dr. Moreno Galleni


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Microbiology Spectrum
Verified
Journal Article
Open access
FAFrancesco Amisano
Francesco Amisano
PMPaola Mercuri
Paola Mercuri
SFSteven Fanara
Steven Fanara
OVOlivier Verlaine
Olivier Verlaine
PMPatrick Motte
Patrick Motte
MGMoreno Galleni
Moreno Galleni
Gram-negative bacteria are a major concern for public health, particularly due to the continuous rise of antibiotic resistance. A major factor that helps the development of resistance is the outer membrane that is essential since it acts as a strong permeability barrier to many antibiotics that are effective against other bacteria. In this study, we determine the specific permeability coefficients for various antibiotics in Pseudomonas aeruginosa strains, which differ from each other for their porin expressions. We showed that OprD and OpdP porins contribute both to internalize meropenem and biapenem. Using qRT-PCR, we demonstrated that their expression is dependent of the various phases of cellular growth. We were able to show how the OpdP porin is less expressed in exponential growth phases, while it tends to be produced when the bacterial culture enters into the latent phase, in an inversely proportional way compared to the OprD porin. The deletion of the OpdP porin, in the presence of meropenem at concentrations equivalent to the MIC values, contributes to the selection of carbapenem-resistant strains. Therefore, the presence of mutations/deletions of the OpdP porin should receive greater consideration from a clinical point of view as the use of meropenem at nonoptimal concentrations could lead to the appearance of resistance phenotypes. IMPORTANCE: Carbapenem-resistant strains of Pseudomonas aeruginosa are among the major threats to public health. The permeability of the outer membrane for the β-lactam antibiotics is one of the major factors that reduce the activity of the antibiotics. In this study, we measure the low permeability coefficient of the P. aeruginosa outer membrane to β-lactams. The methodology we develop to determine the permeability can be applied to other antibiotic families and/or pathogens.

23 July 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
LGLaurent Gavara
Laurent Gavara
FVFederica Verdirosa
Federica Verdirosa
ALAlice Legru
Alice Legru
PMPaola Sandra Mercuri
Paola Sandra Mercuri
LNlionel nauton
lionel nauton
JHJean-Francois Hernandez
Jean-Francois Hernandez
To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with Ki values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL.

21 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SFSimona De Franco
Simona De Franco
JVJulie Vandenameele
Julie Vandenameele
ABAlain Brans
Alain Brans
OVOlivier Verlaine
Olivier Verlaine
KBKaterina Bendak
Katerina Bendak
MVMarylène Vandevenne
Marylène Vandevenne
Transcriptomes consist of several classes of RNA that have wide-ranging but often poorly described functions and the deregulation of which leads to numerous diseases. Engineering of functionalized RNA-binding proteins (RBPs) could therefore have many applications. Our previous studies suggested that the RanBP2-type Zinc Finger (ZF) domain is a suitable scaffold to investigate the design of single-stranded RBPs. In the present work, we have analyzed the natural sequence specificity of various members of the RanBP2-type ZF family and characterized the interaction with their target RNA. Surprisingly, our data showed that natural RanBP2-type ZFs with different RNA-binding residues exhibit a similar sequence specificity and therefore no simple recognition code can be established. Despite this finding, different discriminative abilities were observed within the family. In addition, in order to target a long RNA sequence and therefore gain in specificity, we generated a 6-ZF array by combining ZFs from the RanBP2-type family but also from different families, in an effort to achieve a wider target sequence repertoire. We showed that this chimeric protein recognizes its target sequence (20 nucleotides), both in vitro and in living cells. Altogether, our results indicate that the use of ZFs in RBP design remains attractive even though engineering of specificity changes is challenging.

1 May 2018 in Journal of Molecular Biology
Verified
Journal Article
Closed access
FCF. Cawez
F. Cawez
EDE. Duray
E. Duray
YHY. Hu
Y. Hu
JVJ. Vandenameele
J. Vandenameele
ERE. Romão
E. Romão
MVM. Vandevenne
M. Vandevenne

18 April 2023 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
FCFrédéric Cawez
Frédéric Cawez
PMPaola Sandra Mercuri
Paola Sandra Mercuri
FMFrancisco Javier Morales-Yãnez
Francisco Javier Morales-Yãnez
RMRita Maalouf
Rita Maalouf
MVMarylène Vandevenne
Marylène Vandevenne
MGMoreno Galleni
Moreno Galleni
Three soluble single-domain fragments derived from the unique variable region of camelid heavy-chain antibodies (VHHs) against the CMY-2 β-lactamase behaved as inhibitors. The structure of the complex VHH cAb CMY-2 (254)/CMY-2 showed that the epitope is close to the active site and that the CDR3 of the VHH protrudes into the catalytic site.

1 June 2019 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
RDRaphaël Dutoit
Raphaël Dutoit
MDMaud Delsaute
Maud Delsaute
LCLaetitia Collet
Laetitia Collet
CWCorinne Vander Wauven
Corinne Vander Wauven
DEDany Van Elder
Dany Van Elder
CBCédric Bauvois
Cédric Bauvois